ING Group’s Histogen Inc. Common Stock HSTO Stock Holding History

ING Group’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-100	Closed	-$110K	–	631
2016 Q4	$110K	Buy	+100	New	+$45.4K	﹤0.01%	524

Other funds holding HSTO

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CCM

Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return

ING Group's HSTO Position: Q1 2017 in Review

ING Group sold out of Histogen Inc. Common Stock (HSTO) in Q1 2017, closing a stake of 100 shares — an estimated $110K sold.

ING Group first reported a position in HSTO in Q4 2016 and held it in 1 quarter. The position peaked at $110K in Q4 2016. 43 funds tracked by Wall St. Rank hold HSTO as of Q1 2017.

ING Group reported no remaining Histogen Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
ING Group sold 100 Histogen Inc. Common Stock shares in Q1 2017, an estimated $110K.
ING Group first reported a position in Histogen Inc. Common Stock in Q4 2016 and held it in 1 quarter.
ING Group's Histogen Inc. Common Stock position peaked at $110K in Q4 2016.
43 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2017.

Based on ING Group's 13F filing for Q1 2017, filed 1 May 2017.